lexisnexis whitepaper

Download whitepaper – Pharmaceutical & Life sciences: Third Party Due Diligence

Whitepaper by LexisNexis Few industries are as exposed to risk as the pharmaceuticals and life sciences. It is no longer enough to carry out basic checks alone on third-parties. Companies must engage in enhanced due diligence if they are to avoid the large fines and regulatory penalties. Effective third-party due diligence is increasingly recognized as a strategic driver for sustainable …

crm, marketing, life sciences, pharma, sales, strategy, speciality

Download: 10 Reasons Why “CRM-in-a-Box” Doesn’t Work for Specialty Life Sciences

  Specialty drug or device selling is as different from the traditional primary care business model as podiatrists are from pediatricians. Today’s industry is moving away from armies of sales representatives to smaller, more focused specialty sales teams. The entire selling process (indeed, the entire industry) is under pressure to perform more efficiently with fewer resources, to find and implement better tools and …

TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm

Tata Consultancy Services, a leading IT services, consulting and business solutions organization recently announced that it has been designated as a Leader in Life Science Drug Safety Services (DSS) by the prominent global market intelligence firm IDC. The report cites TCS' significant industry expertise and wide range of capabilities as key leadership characteristics. "TCS' large life science customer base, broad …